Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

966
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

563
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

577
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
577

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus.

Journal of translational autoimmunity·2026
Same author

Monocytes from patients with chronic non-bacterial osteomyelitis (CNO) exhibit increased 'classically activated' phenotypes and altered DNA methylation patterns.

Clinical immunology (Orlando, Fla.)·2026
Same author

Reply.

ACR open rheumatology·2026
Same author

How loss-of-function mutations in <i>IFIH1</i> contribute to infectious and/or inflammatory disease - a systematic review.

Journal of translational autoimmunity·2026
Same author

Treatment of pediatric chronic nonbacterial osteomyelitis - a systematic review.

Autoimmunity reviews·2026
Same author

Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort study.

Rheumatology (Oxford, England)·2026
Same journal

Intraoperative desaturation in pediatric patients at high altitude: incidence, risk factors, and a non-linear body weight safety threshold.

Frontiers in pediatrics·2026
Same journal

Clinical phenotypes and genetic analysis of 30 children with Gitelman syndrome.

Frontiers in pediatrics·2026
Same journal

Seeking a viable perioperative preemptive analgesia regimen: a prospective, randomized, controlled, double-blind superiority study of intravenous acetaminophen in children undergoing adenotonsillectomy.

Frontiers in pediatrics·2026
Same journal

Alterations in urinary metals following pulsed 660 nm photobiomodulation in a pediatric patient with autism spectrum disorder: a case report.

Frontiers in pediatrics·2026
Same journal

A study on differences in lung function development and longitudinal patterns between preterm infants of different gestational ages and term infants.

Frontiers in pediatrics·2026
Same journal

Effects of metabolic syndrome on pulmonary infection in pediatric bronchial asthma: a narrative review.

Frontiers in pediatrics·2026
See all related articles

Related Experiment Video

Updated: Feb 7, 2026

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.4K

Kawasaki Disease.

Christian M Hedrich1,2,3, Anja Schnabel3, Toni Hospach4

  • 1Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

Frontiers in Pediatrics
|July 26, 2018
PubMed
Summary
This summary is machine-generated.

Kawasaki disease (KD) is a critical childhood vasculitis affecting medium vessels. Early diagnosis and treatment are vital to prevent serious heart complications like coronary artery aneurysms.

Keywords:
IvIg therapyfever without infectioninflammatory disorderskawasaki diseasevasculitis

More Related Videos

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.3K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

18.1K

Related Experiment Videos

Last Updated: Feb 7, 2026

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.4K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.3K
High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

18.1K

Area of Science:

  • Pediatrics
  • Rheumatology
  • Cardiology

Background:

  • Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed nations.
  • It is an acute-onset systemic vasculitis primarily affecting medium-sized arteries.
  • Delayed diagnosis and treatment increase the risk of coronary artery aneurysms, occurring in up to 25% of cases.

Purpose of the Study:

  • To provide a comprehensive overview of Kawasaki disease.
  • To discuss current knowledge on clinical presentations, pathophysiology, and complications.
  • To review available pharmaceutical treatments for KD.

Main Methods:

  • Literature review of current understanding of Kawasaki disease.
  • Synthesis of information on clinical features, etiology, and sequelae.
  • Analysis of established and emerging therapeutic strategies.

Main Results:

  • KD presents acutely and affects medium vessels, predominantly in infants and toddlers.
  • Coronary artery abnormalities are a significant complication of untreated or delayed-treated KD.
  • Current literature highlights various clinical manifestations and pathophysiological insights.

Conclusions:

  • Kawasaki disease requires prompt recognition and management to mitigate cardiovascular risks.
  • Understanding the disease's complexities is crucial for effective treatment strategies.
  • Ongoing research aims to improve diagnostic accuracy and therapeutic outcomes for KD.